47 | | - | amending 63 O.S. 2021, Section 2 -309, as last amended |
---|
48 | | - | by Section 1, Chapter 259, O.S .L. 2021, which relates |
---|
49 | | - | to electronic prescriptions; clarifying certain |
---|
50 | | - | exception; amending 63 O.S. 2021, Section 2-309D, as |
---|
51 | | - | last amended by Section 2 of Enrolled Senate Bill No. |
---|
52 | | - | 1151 of the 2nd Session of the 58th Oklahoma |
---|
53 | | - | Legislature, which relates to the central repository; |
---|
54 | | - | requiring Oklahoma State Bureau of Narcotics and |
---|
55 | | - | Dangerous Drugs Control to make certain determination |
---|
56 | | - | upon certain notification; authorizing Bureau to |
---|
57 | | - | report certain information to practitioner licensing |
---|
58 | | - | boards; requiring certain health care providers and |
---|
59 | | - | employers to carry specified malpractice insurance; |
---|
71 | | - | infection control requirements; providing certain |
---|
72 | | - | quality assurance requirements; stipulating certain |
---|
73 | | - | data collection and reporting requirements; requiring |
---|
74 | | - | establishment of certain written policy; directing |
---|
| 51 | + | infection control requirements; providing health and |
---|
| 52 | + | safety requirements; providing certain quality |
---|
| 53 | + | assurance requirements; stipulating certain data |
---|
| 54 | + | collection and reporting requirements; providing that |
---|
| 55 | + | designated physician is respo nsible for ensuring |
---|
| 56 | + | compliance with all requirements; providing |
---|
| 57 | + | penalties; directing promulgation of rules; amending |
---|
| 58 | + | 59 O.S. 2011, Section 355.1, as amended by Section |
---|
| 59 | + | 21, Chapter 230, O.S.L. 2015 (59 O.S. Supp. 2020, |
---|
| 60 | + | Section 355.1), which relates to dispe nsation of |
---|
| 61 | + | dangerous drugs; provi ding certain limitations on |
---|
| 62 | + | dispensation of controlled dangerous substances; |
---|
| 63 | + | providing exception; providing for codification; and |
---|
| 64 | + | providing an effective date. |
---|
101 | | - | certain investigation by Bureau; providing penalties; |
---|
102 | | - | directing promulgation of rules; providing certain |
---|
103 | | - | construction; amending 63 O.S. 2021, Section 942 , |
---|
104 | | - | which relates to medical examiner reports; requiring |
---|
105 | | - | Chief Medical Examiner to furnish certain reports to |
---|
106 | | - | the Bureau; providing for codification; and providing |
---|
107 | | - | an effective date. |
---|
| 101 | + | "[ controlled dangerous substances - requiring pain |
---|
| 102 | + | management clinics to register wit h State Board of |
---|
| 103 | + | Medical Licensure and Supervision - requiring |
---|
| 104 | + | facility operations to cease when registration is |
---|
| 105 | + | revoked or suspended - prohibiting physicians from |
---|
| 106 | + | practicing medicine in unregistered pain |
---|
| 107 | + | management clinics - effective date ] |
---|
| 108 | + | |
---|
112 | | - | SECTION 1. AMENDATORY 63 O.S . 2021, Section 2-309, as |
---|
113 | | - | last amended by Section 1, Chapter 259, O. S.L. 2021, is amended to |
---|
114 | | - | read as follows: |
---|
115 | | - | Section 2-309. A. 1. Except for dosages medically require d |
---|
116 | | - | for a period not to exceed forty -eight (48) hours which are |
---|
117 | | - | administered by or on di rection of a practitioner, other than a |
---|
118 | | - | pharmacist, or medication dispensed directly by a pract itioner, |
---|
119 | | - | other than a pharmacist, to an ultimate u ser, no controlled |
---|
120 | | - | dangerous substance included in Schedule II, which is a prescription |
---|
121 | | - | drug as determined unde r regulation promulgated by the Board o f |
---|
122 | | - | Pharmacy, shall be dispensed without an electronic pre scription of a |
---|
123 | | - | practitioner; provided, that in eme rgency situations, as pre scribed |
---|
124 | | - | by the Board of Pharmacy by regulation, such drug may be dispensed |
---|
125 | | - | upon oral prescription reduced promptly to writing and filed by the |
---|
126 | | - | pharmacist in a manner to be prescribe d by rules and regulations of |
---|
127 | | - | the Director of the Oklahoma State Bureau of Narcotics and Dangerous |
---|
128 | | - | Drugs Control. |
---|
| 113 | + | SECTION 1. NEW LAW A new section of law to be codified |
---|
| 114 | + | in the Oklahoma Statutes as Section 2 -1101 of Title 63, un less there |
---|
| 115 | + | is created a duplication in numbering, reads as follows: |
---|
| 116 | + | As used in this act: |
---|
| 117 | + | 1. "Board eligible" means successful completion of an |
---|
| 118 | + | anesthesia, physical medicine and rehabilitation, rheumatology or |
---|
| 119 | + | neurology residency program approved by the Ac creditation Council |
---|
| 120 | + | for Graduate Medical Education or the American O steopathic |
---|
| 121 | + | Association for a period of six (6) years from successful completion |
---|
| 122 | + | of such residency program; |
---|
| 123 | + | 2. "Chronic nonmalignant pain" means pain unrelated to cancer |
---|
| 124 | + | which persists beyond the usual course of disease or the injury that |
---|
| 125 | + | is the cause of the pain or more than ninety (90) calendar days |
---|
| 126 | + | after surgery; and |
---|
155 | | - | 2. Electronic prescrib ing shall be utilized fo r Schedules II, |
---|
156 | | - | III, IV and V, subject to the requirements set forth in 21 CFR, |
---|
157 | | - | Section 1311 et seq. |
---|
158 | | - | 3. An electronic prescription with electron ic signature may |
---|
159 | | - | serve as an original prescription, subject to the requirements set |
---|
160 | | - | forth in 21 CFR, Section 13 11 et seq. |
---|
161 | | - | 4. Prescriptions shall be r etained in conformity with the |
---|
162 | | - | requirements of this sect ion and Section 2-307 of this title. No |
---|
163 | | - | prescription for a Schedule II sub stance may be refilled. |
---|
164 | | - | 5. The electronic prescription requir ement provided for in th is |
---|
165 | | - | section shall not apply to prescript ions for controlled dangerous |
---|
166 | | - | substances issued by any o f the following: |
---|
167 | | - | a. a person licensed to practice veterinary medicine, |
---|
168 | | - | b. a practitioner who experiences temporary technological |
---|
169 | | - | or electrical failure or other e xtenuating |
---|
170 | | - | circumstance that prevents t he prescription from being |
---|
171 | | - | transmitted electronically; p rovided, however, that |
---|
172 | | - | the practitioner documents the reason for this |
---|
173 | | - | exception in the medical record of the patient, |
---|
174 | | - | c. a practitioner, other than a pharmacist, who dispenses |
---|
175 | | - | directly to an ultimate user, |
---|
176 | | - | d. a practitioner who orders a controlled dangerou s |
---|
177 | | - | substance to be administered through an on -site |
---|
178 | | - | pharmacy in: |
---|
| 153 | + | 3. "Pain management clinic" or "clinic" means any publicly or |
---|
| 154 | + | privately owned facility: |
---|
| 155 | + | a. that advertises in any medium for any type of pain |
---|
| 156 | + | management services, and |
---|
| 157 | + | b. where in any month a majority of patients are |
---|
| 158 | + | prescribed opioids, benzodiazepines, barbiturates or |
---|
| 159 | + | carisoprodol for the treatment of chronic nonmalignant |
---|
| 160 | + | pain. |
---|
| 161 | + | SECTION 2. NEW LAW A ne w section of law to be codified |
---|
| 162 | + | in the Oklahoma Statutes as Section 2-1102 of Title 63, unless there |
---|
| 163 | + | is created a duplication in numbering, reads as follows: |
---|
| 164 | + | A. Each pain management clinic shall register with the State |
---|
| 165 | + | Board of Medical Licensure and Super vision unless: |
---|
| 166 | + | 1. The majority of the physicians who provide servic es in the |
---|
| 167 | + | clinic primarily provide surgical services; |
---|
| 168 | + | 2. The clinic is affiliated with an accredited medical school |
---|
| 169 | + | at which training is provided for medical students, residents or |
---|
| 170 | + | fellows; |
---|
| 171 | + | 3. The clinic does not prescribe controlled dangerous |
---|
| 172 | + | substances for the treatment of pain; |
---|
| 173 | + | 4. The clinic is wholly owned and operated by one or more |
---|
| 174 | + | board-eligible or board-certified anesthesiologists, physiatrists, |
---|
| 175 | + | rheumatologists or neurologists; o r |
---|
205 | | - | (1) a hospital as defined in Section 1-701 of this |
---|
206 | | - | title, |
---|
207 | | - | (2) a nursing facility as defined in Sec tion 1-1902 |
---|
208 | | - | of this title, |
---|
209 | | - | (3) a hospice inpatient facility as defined in |
---|
210 | | - | Section 1-860.2 of this title, |
---|
211 | | - | (4) an outpatient dialysis facility, |
---|
212 | | - | (5) a continuum of care faci lity as defined in |
---|
213 | | - | Section 1-890.2 of this title, or |
---|
214 | | - | (6) a penal institution listed in Section 509 of |
---|
215 | | - | Title 57 of the Oklahom a Statutes, |
---|
216 | | - | e. a practitioner who orders a controlled da ngerous |
---|
217 | | - | substance to be administered through a hos pice program |
---|
218 | | - | as defined in Section 1-860.2 of this title including |
---|
219 | | - | but not limited to a hospice program tha t provides |
---|
220 | | - | outpatient services, |
---|
221 | | - | f. a practitioner who writes a prescription to be |
---|
222 | | - | dispensed by a pharmacy located on federal property, |
---|
223 | | - | provided the practitioner documents the reason for |
---|
224 | | - | this exception in the medical record of the patient, |
---|
225 | | - | or |
---|
226 | | - | g. a practitioner that has received a waiver or extension |
---|
227 | | - | from his or her licensing board. |
---|
| 202 | + | 5. The clinic is wholly owned and operated by a physician |
---|
| 203 | + | multispecialty practice where one or more board -eligible or board- |
---|
| 204 | + | certified medical specialists, who have also completed fellowships |
---|
| 205 | + | in pain medicine approved by the Accreditation Council for Gra duate |
---|
| 206 | + | Medical Education or who are also certified in pain medicine b y the |
---|
| 207 | + | American Board of Pain Medicine or a board approved by the American |
---|
| 208 | + | Board of Physician Specialties, the American Association of |
---|
| 209 | + | Physician Specialists or the American Osteopathic Asso ciation, |
---|
| 210 | + | perform interventional pain procedures of the type routinel y billed |
---|
| 211 | + | using surgical codes. |
---|
| 212 | + | B. Each clinic location shall be registered separately |
---|
| 213 | + | regardless of whether the clinic is operated under the same business |
---|
| 214 | + | name or management as another cl inic. |
---|
| 215 | + | C. As a part of registration, a clinic shall designate a |
---|
| 216 | + | physician who is responsible for complying with all requirements |
---|
| 217 | + | related to registration and operation of the clinic in compliance |
---|
| 218 | + | with this act. Within ten (10) calendar days after terminati on of a |
---|
| 219 | + | designated physician, the clinic shall notify the State Boar d of |
---|
| 220 | + | Medical Licensure and Supervision of the identity of another |
---|
| 221 | + | designated physician for that clinic. The designated physician |
---|
| 222 | + | shall have a full, active and unencumbered license pursuan t to |
---|
| 223 | + | Section 480 et seq. or Section 620 et seq. of Title 59 of the |
---|
| 224 | + | Oklahoma Statutes and shall practice at the clinic location for |
---|
| 225 | + | which the physician has assumed responsibility. Failing to have a |
---|
254 | | - | 6. Electronic prescri ptions shall not be utilized under the |
---|
255 | | - | following circumstances: |
---|
256 | | - | a. compound prescriptions containing two or more |
---|
257 | | - | commercially available products or two or more a ctive |
---|
258 | | - | pharmaceutical ingredients, |
---|
259 | | - | b. compounded infusion prescriptions containing two or |
---|
260 | | - | more commercially available products or two or more |
---|
261 | | - | active pharmaceutical ingredi ents, |
---|
262 | | - | c. prescriptions issued under approved research |
---|
263 | | - | protocols, or |
---|
264 | | - | d. if the practitioner determines that an electronic |
---|
265 | | - | prescription cannot be issued in a timely manner and |
---|
266 | | - | the condition of the patient is at risk. |
---|
267 | | - | 7. A pharmacist who receives a written, oral or facsimile |
---|
268 | | - | prescription shall not be required to verify that the prescription |
---|
269 | | - | falls under one of the exceptions provid ed for in paragraph 6 of |
---|
270 | | - | this subsection. Pharmacists m ay continue to dispense medications |
---|
271 | | - | from otherwise valid written, oral or f acsimile prescriptions that |
---|
272 | | - | are consistent with the provisions of this section. |
---|
273 | | - | 8. Practitioners shall indicate in the healt h record of a |
---|
274 | | - | patient that an exception to the electroni c prescription requirement |
---|
275 | | - | was utilized. |
---|
276 | | - | 9. All prescriptions issued pursu ant to paragraphs 5 and 6 of |
---|
277 | | - | this subsection shall be issued on an official prescripti on form |
---|
| 252 | + | licensed designated physician practicing at the location o f the |
---|
| 253 | + | registered clinic may be the basis for a summary suspension of the |
---|
| 254 | + | clinic registration certificate as described in this section. |
---|
| 255 | + | D. The State Board of Medical Licensure and Supervision shall |
---|
| 256 | + | deny registration to any pain management clinic owned by o r with any |
---|
| 257 | + | contractual or employment relationship with a physician: |
---|
| 258 | + | 1. Whose Drug Enforcement Administration number has ever been |
---|
| 259 | + | revoked; |
---|
| 260 | + | 2. Whose application for a license to prescribe, dispense or |
---|
| 261 | + | administer a controlled substance has been denied for disciplinary |
---|
| 262 | + | action by the appropriate medical regulatory board of t he physician; |
---|
| 263 | + | or |
---|
| 264 | + | 3. Who has been convicted of or pleaded guilty or nolo |
---|
| 265 | + | contendere to, regardless of adjudication, an offense that |
---|
| 266 | + | constitutes a felony for receipt of illicit or diverted drugs, |
---|
| 267 | + | including a controlled substance listed in Schedule I, II, II I, IV |
---|
| 268 | + | or V of the Uniform Controlled Dangerous Substances Act, in this |
---|
| 269 | + | state, any other state or the United States. |
---|
| 270 | + | E. If the State Board of Medical Licensure and Supervision |
---|
| 271 | + | finds that a pain management clinic is owned, directly or |
---|
| 272 | + | indirectly, by a perso n meeting any criteria listed in subsection D |
---|
| 273 | + | of this section, the State Board of Medical Licensure and |
---|
| 274 | + | Supervision shall revoke the certificate of registration previously |
---|
| 275 | + | issued by the State Board of Medical Licensure and Supervision. As |
---|
304 | | - | provided by the Oklahoma State Bureau of Narcotics and Dangerous |
---|
305 | | - | Drugs Control. |
---|
306 | | - | 10. a. Effective January 1, 2020, practitioners shall |
---|
307 | | - | register with the Oklahoma S tate Bureau of Narcotics |
---|
308 | | - | and Dangerous Drugs Control in order to be issued |
---|
309 | | - | official prescription forms. Such registration sh all |
---|
310 | | - | include, but not be limited to, the primary address |
---|
311 | | - | and the address of each place of business to be |
---|
312 | | - | imprinted on official presc ription forms. Any change |
---|
313 | | - | to a registered practitioner 's registered address |
---|
314 | | - | shall be promptly reported to the practitioner 's |
---|
315 | | - | licensing board and the Bureau by the practitioner in |
---|
316 | | - | a manner approved by the Bureau. |
---|
317 | | - | b. A practitioner's registration shall be w ithout fee and |
---|
318 | | - | subject to approval by the Bureau. Such registration |
---|
319 | | - | shall be valid for a period of two (2) years and may |
---|
320 | | - | be denied, suspended or revoked by the Bureau upon a |
---|
321 | | - | finding by the Bureau or licensing board that the |
---|
322 | | - | registered practitioner has had any license to |
---|
323 | | - | practice a medical profession revoked or suspended by |
---|
324 | | - | any state or federal agency. |
---|
325 | | - | c. Where the Bureau has re voked the registration of a |
---|
326 | | - | registered practitioner, the Bureau may revoke or |
---|
327 | | - | cancel any official prescrip tion forms in the |
---|
| 302 | + | determined by rule, the State Board of Medical Licensure and |
---|
| 303 | + | Supervision may grant an exemption to denying a registration or |
---|
| 304 | + | revoking a previously issued registration if more than five (5) |
---|
| 305 | + | years have elapsed since adjudication. As used in this section, the |
---|
| 306 | + | term "convicted" includes an adjudication of guilt following a plea |
---|
| 307 | + | of guilty or nolo contendere or the forfeiture of a bond when |
---|
| 308 | + | charged with a crime. |
---|
| 309 | + | F. If the registration of a pain management clini c is revoked |
---|
| 310 | + | or suspended, the designated physician of the pain mana gement |
---|
| 311 | + | clinic, the owner or lessor of the pain management clinic property, |
---|
| 312 | + | the manager and the proprietor shall cease to operate the facility |
---|
| 313 | + | as a pain management clinic as of the effectiv e date of the |
---|
| 314 | + | suspension or revocation. |
---|
| 315 | + | G. If a pain management cli nic registration is revoked or |
---|
| 316 | + | suspended, the designated physician of the pain management clinic, |
---|
| 317 | + | the owner or lessor of the clinic property, the manager or the |
---|
| 318 | + | proprietor is responsible f or removing all signs and symbols |
---|
| 319 | + | identifying the premises as a pain management clinic. |
---|
| 320 | + | H. If the clinic’s registration is revoked, any person named in |
---|
| 321 | + | the registration documents of the pain management clinic, including |
---|
| 322 | + | persons owning or operating the pai n management clinic, shall not, |
---|
| 323 | + | as an individual or as a part of a g roup, apply to operate a pain |
---|
| 324 | + | management clinic for one (1) year after the date the registration |
---|
| 325 | + | is revoked. |
---|
354 | | - | possession of the registered practitioner. Any |
---|
355 | | - | revocation or any suspension shall require th e |
---|
356 | | - | registered practitioner to return all unused official |
---|
357 | | - | prescription forms to the Bureau within fifteen (15) |
---|
358 | | - | calendar days after the date of the written |
---|
359 | | - | notification. |
---|
360 | | - | d. A practitioner that has had any license to practice |
---|
361 | | - | terminated, revoked or suspended b y a state or federal |
---|
362 | | - | agency may, upon restoration of such license or |
---|
363 | | - | certificate, register to b e issued official |
---|
364 | | - | prescription forms. |
---|
365 | | - | 11. a. Except as provided in subparag raph f of this |
---|
366 | | - | paragraph, the Bureau shall issue official |
---|
367 | | - | prescription forms free of c harge only to registered |
---|
368 | | - | practitioners in this state. Such forms shall not be |
---|
369 | | - | transferable. The number of official prescription |
---|
370 | | - | forms issued to a registered practitione r at any time |
---|
371 | | - | shall be at the discretion of the Bureau. |
---|
372 | | - | b. Official prescription forms issued to a registered |
---|
373 | | - | practitioner shall be imprinted only with the primary |
---|
374 | | - | address and other addresses listed on the registration |
---|
375 | | - | of the practitioner. Such prescripti ons shall be sent |
---|
376 | | - | only to the primary address of the registered |
---|
377 | | - | practitioner. |
---|
| 352 | + | I. The period of suspension for the registration of a pain |
---|
| 353 | + | management clinic shall be prescribed by the State Board of Medical |
---|
| 354 | + | Licensure and Supervision but shall not exceed one (1) year. |
---|
| 355 | + | J. A change of ownership of a registered pain management clinic |
---|
| 356 | + | requires submission of a new registration application. |
---|
| 357 | + | SECTION 3. NEW LAW A new section of law to be codified |
---|
| 358 | + | in the Oklahoma Statutes as Section 2-1103 of Title 63, unless there |
---|
| 359 | + | is created a duplication in numbering, reads as follows: |
---|
| 360 | + | A. A physician shall not practice medicine in a pain management |
---|
| 361 | + | clinic if the clinic is not registered with the State Board of |
---|
| 362 | + | Medical Licensure and Supervision as required by this act. Any |
---|
| 363 | + | physician who qualifies to practice medicine in a pain management |
---|
| 364 | + | clinic pursuant to rules adopted by the appropriate medical |
---|
| 365 | + | regulatory board of the physician may continue to practice medicine |
---|
| 366 | + | in a pain management clinic as long as the physician continues to |
---|
| 367 | + | meet the qualifications prescribed in the rules. A physician who |
---|
| 368 | + | violates this subsection is subject to disciplinary action by the |
---|
| 369 | + | appropriate medical regulatory board of the physician. |
---|
| 370 | + | B. Only a physician licensed pursuant to Section 480 et seq. or |
---|
| 371 | + | Section 620 et seq. of Title 59 of the Oklahoma Statutes may |
---|
| 372 | + | prescribe a controlled dangerous substance on the premises of a |
---|
| 373 | + | registered pain management clinic. No person shall dispense any |
---|
| 374 | + | controlled dangerous substance on the premises of a pain management |
---|
| 375 | + | clinic. |
---|
404 | | - | c. Official prescription forms issued to a regi stered |
---|
405 | | - | practitioner shall be used only by the practition er to |
---|
406 | | - | whom they are issued. |
---|
407 | | - | d. The Bureau may revoke or cancel official pre scription |
---|
408 | | - | forms in possession of registered practitioners when |
---|
409 | | - | the license of such pra ctitioner is suspended, |
---|
410 | | - | terminated or revoked. |
---|
411 | | - | e. Official prescription forms of registered |
---|
412 | | - | practitioners who are deceased or who no longer |
---|
413 | | - | prescribe shall be returned to the Bureau at a |
---|
414 | | - | designated address. If the registered practitioner is |
---|
415 | | - | deceased, it is the responsibility of the registered |
---|
416 | | - | practitioner's estate or lawful designee to return |
---|
417 | | - | such forms. |
---|
418 | | - | f. The Bureau may issue official prescripti on forms to |
---|
419 | | - | employees or agents of the Bureau and other government |
---|
420 | | - | agencies for the purpose of preventing, iden tifying, |
---|
421 | | - | investigating and prosecuting unacceptable or illegal |
---|
422 | | - | practices by providers and other persons and assisting |
---|
423 | | - | in the recovery of overpaym ents under any program |
---|
424 | | - | operated by the state or paid for with state funds. |
---|
425 | | - | Such prescription forms shall be is sued for this |
---|
426 | | - | purpose only to individua ls who are authorized to |
---|
427 | | - | conduct investigations on behal f of the Bureau or |
---|
| 402 | + | C. A physician, a physician assistant or an Advanced Practice |
---|
| 403 | + | Registered Nurse shall perform a physical examination of a patient |
---|
| 404 | + | on the same day that the physician prescribes a controlled substance |
---|
| 405 | + | to a patient at a pain management clinic. |
---|
| 406 | + | D. A physician authorized to prescribe controlled dangerous |
---|
| 407 | + | substances who practices at a pain management clinic is responsible |
---|
| 408 | + | for maintaining the control and security of his or her prescription |
---|
| 409 | + | blanks and any other method used for prescribing controlled |
---|
| 410 | + | dangerous substance pain medication. The physician shall notify, in |
---|
| 411 | + | writing, the State Board of Medical Licensure and Supervision within |
---|
| 412 | + | twenty-four (24) hours following any theft or loss of a prescription |
---|
| 413 | + | blank or breach of any other method for prescribing pain medication. |
---|
| 414 | + | E. The designated physician of a pain management clinic shall |
---|
| 415 | + | notify the applicable board in writing of the date of termin ation of |
---|
| 416 | + | employment within ten (10) calendar days after terminating his or |
---|
| 417 | + | her employment with a pain management clinic that is required to be |
---|
| 418 | + | registered pursuant to this act. Each physician practicing in a |
---|
| 419 | + | pain management clinic shall advise the State Bo ard of Medical |
---|
| 420 | + | Licensure and Supervision, in writing, within ten (10 ) calendar days |
---|
| 421 | + | after beginning or ending his or her practice at a pain management |
---|
| 422 | + | clinic. |
---|
| 423 | + | F. Each physician practicing in a pain management clinic is |
---|
| 424 | + | responsible for ensuring compliance with the following facility and |
---|
| 425 | + | physical operations requirements: |
---|
454 | | - | other government agencies as pa rt of their official |
---|
455 | | - | duties. Individuals and agencies receiving such |
---|
456 | | - | prescription forms for this purpose shall provide |
---|
457 | | - | appropriate assurances to the Bureau that adequate |
---|
458 | | - | safeguards and security measures ar e in place to |
---|
459 | | - | prevent the use of such prescription forms for |
---|
460 | | - | anything other than official government purposes. |
---|
461 | | - | 12. a. Adequate safeguards and security measures s hall be |
---|
462 | | - | undertaken by registered practi tioners holding |
---|
463 | | - | official prescription forms to assure ag ainst the |
---|
464 | | - | loss, destruction, theft or unauthorized use of the |
---|
465 | | - | forms. Registered practitioners shall maintain a |
---|
466 | | - | sufficient but not excessive supply of such forms in |
---|
467 | | - | reserve. |
---|
468 | | - | b. Registered practitioner s shall immediately notify the |
---|
469 | | - | Bureau, in a manner desig nated by the Bureau, upon |
---|
470 | | - | their knowledge of the l oss, destruction, theft o r |
---|
471 | | - | unauthorized use of any official prescription forms |
---|
472 | | - | issued to them, as well as the f ailure to receive |
---|
473 | | - | official prescription forms within a reasonable time |
---|
474 | | - | after ordering them from the Bureau. |
---|
475 | | - | c. Registered practitioners shall imm ediately notify the |
---|
476 | | - | Bureau upon their knowledge of any diversion or |
---|
| 452 | + | 1. A pain management clinic shall be located and operated at a |
---|
| 453 | + | publicly accessible fixed location and shall: |
---|
| 454 | + | a. display a sign that can be viewed by the public that |
---|
| 455 | + | contains the clinic name , hours of operations and a |
---|
| 456 | + | street address, |
---|
| 457 | + | b. have a publicly liste d telephone number and a |
---|
| 458 | + | dedicated phone number to send and receive facsimiles, |
---|
| 459 | + | c. have a reception and waiting area, |
---|
| 460 | + | d. provide a restroom, |
---|
| 461 | + | e. have private patient examination rooms, |
---|
| 462 | + | f. have treatment rooms, if treatment is being provided |
---|
| 463 | + | to the patients, and |
---|
| 464 | + | g. display a printed sign located in a conspicuous place |
---|
| 465 | + | in the waiting room viewable by the public with the |
---|
| 466 | + | name and contact information of the clinic’s |
---|
| 467 | + | designated physician and the names of all physicians |
---|
| 468 | + | practicing in the clinic; and |
---|
| 469 | + | 2. This section does not excuse a physician from providing any |
---|
| 470 | + | treatment or performing any medical duty without the proper |
---|
| 471 | + | equipment and materials as required by the standard of care. This |
---|
| 472 | + | section does not supersede the level of care, skill or treatment |
---|
| 473 | + | recognized in general law related to health care licensure. |
---|
503 | | - | suspected diversion of drugs pursuant to th e loss, |
---|
504 | | - | theft or unauthorized use of pr escriptions. |
---|
505 | | - | B. 1. Except for dosages medically requir ed for a period not |
---|
506 | | - | to exceed seventy-two (72) hours which are administered by or on |
---|
507 | | - | direction of a practitioner, other than a pharmacist, or medication |
---|
508 | | - | dispensed directly by a practitioner, other tha n a pharmacist, to an |
---|
509 | | - | ultimate user, no controlled dange rous substance included in |
---|
510 | | - | Schedule III or IV, whi ch is a prescription drug as determined under |
---|
511 | | - | regulation promulgated by the Board of Pharmacy, shall be dispens ed |
---|
512 | | - | without an electronic prescription. |
---|
513 | | - | 2. Any prescription for a controlled dangerous substanc e in |
---|
514 | | - | Schedule III, IV or V may not be filled or re filled more than six |
---|
515 | | - | (6) months after the date thereof or be refilled more than five |
---|
516 | | - | times after the date of th e prescription, unless renewed by the |
---|
517 | | - | practitioner. |
---|
518 | | - | C. Whenever it appears to the Director of the Oklahoma State |
---|
519 | | - | Bureau of Narcotics and Dangero us Drugs Control that a d rug not |
---|
520 | | - | considered to be a prescription drug under existing state law or |
---|
521 | | - | regulation of the Board of Pharmacy should be so con sidered because |
---|
522 | | - | of its abuse potential, the Director sha ll so advise the Board of |
---|
523 | | - | Pharmacy and furnish to the Board all available d ata relevant |
---|
524 | | - | thereto. |
---|
525 | | - | D. 1. "Prescription", as used in this section, means a |
---|
526 | | - | written, oral or electronic order by a practit ioner to a pharmacist |
---|
| 500 | + | G. Each physician practicing in a pain management clinic is |
---|
| 501 | + | responsible for ensuring compliance with the following infection |
---|
| 502 | + | control requirements: |
---|
| 503 | + | 1. The clinic shall maintain equipment and supplies to suppor t |
---|
| 504 | + | infection prevention and control activities; |
---|
| 505 | + | 2. The clinic shall identify infection risks based on the |
---|
| 506 | + | following: |
---|
| 507 | + | a. geographic location, community and population served, |
---|
| 508 | + | b. the care, treatment and services it provides, and |
---|
| 509 | + | c. an analysis of its infecti on surveillance and control |
---|
| 510 | + | data; and |
---|
| 511 | + | 3. The clinic shall maintain written infection prevention |
---|
| 512 | + | policies and procedures that address the following: |
---|
| 513 | + | a. prioritized risks, |
---|
| 514 | + | b. limiting unprotected exposure to pathogens, |
---|
| 515 | + | c. limiting the transmission of infect ions associated |
---|
| 516 | + | with procedures performed in the clinic, and |
---|
| 517 | + | d. limiting the transmission of infections associated |
---|
| 518 | + | with the clinic’s use of medical equipment, devices |
---|
| 519 | + | and supplies. |
---|
| 520 | + | H. Each physician practicing in a pain management clinic is |
---|
| 521 | + | responsible for ensuring that the clinic, including its grounds, |
---|
| 522 | + | buildings, furniture, appliances and equipment is structurally |
---|
553 | | - | for a controlled dangerous substan ce for a particular patient, which |
---|
554 | | - | specifies the date of its issue, and the full name and address of |
---|
555 | | - | the patient and, if the controlled dangerous substance is pr escribed |
---|
556 | | - | for an animal, the species of the animal, the name and quantity of |
---|
557 | | - | the controlled dangerous substance prescribed, the directions for |
---|
558 | | - | use, the name and address of the owner of the animal and, if |
---|
559 | | - | written, the signature of the practitioner. |
---|
560 | | - | 2. "Registered practitioner", as used in this section, means a |
---|
561 | | - | licensed practitioner duly registered wi th the Oklahoma State Bureau |
---|
562 | | - | of Narcotics and Dang erous Drugs Control to be issued official |
---|
563 | | - | prescription forms. |
---|
564 | | - | E. No person shall solicit, dispense, receive or deliver any |
---|
565 | | - | controlled dangerous subst ance through the mail, unless the ultimate |
---|
566 | | - | user is personally known to the practitioner and circumstances |
---|
567 | | - | clearly indicate such met hod of delivery is in the best interest of |
---|
568 | | - | the health and welfare of the ultimate user . |
---|
569 | | - | SECTION 2. AMENDATORY 63 O.S. 2021, Section 2 -309D, as |
---|
570 | | - | last amended by Section 2 of Enrolled Senate Bill No. 1151 of the |
---|
571 | | - | 2nd Session of the 58th Oklahoma Legislature , is amended to read as |
---|
572 | | - | follows: |
---|
573 | | - | Section 2-309D. A. The information collected at the central |
---|
574 | | - | repository pursuant to the Anti -Drug Diversion Act shall be |
---|
575 | | - | confidential and shall not be open to the public. Ac cess to the |
---|
576 | | - | information shall be limited to: |
---|
| 549 | + | sound, in good repair, clean and free from health and safety |
---|
| 550 | + | hazards. |
---|
| 551 | + | I. The designated physician is responsible for ensuring |
---|
| 552 | + | compliance with the following quality assurance requirements: |
---|
| 553 | + | 1. Each pain management clinic shall have an ongoing quality |
---|
| 554 | + | assurance program that objectively and systematically: |
---|
| 555 | + | a. monitors and evaluate s the quality and appropriateness |
---|
| 556 | + | of patient care, |
---|
| 557 | + | b. evaluates methods to improve patient care, |
---|
| 558 | + | c. identifies and corrects deficiencies within the |
---|
| 559 | + | facility, |
---|
| 560 | + | d. alerts the designated physician to identify and |
---|
| 561 | + | resolve recurring problems, and |
---|
| 562 | + | e. provides for opportunities to improve the facility’s |
---|
| 563 | + | performance and to enhance and improve the quality of |
---|
| 564 | + | care provided to the public; and |
---|
| 565 | + | 2. The designated physician shall establish a quality assurance |
---|
| 566 | + | program that includes the following components: |
---|
| 567 | + | a. the identification, investigation and analysis of the |
---|
| 568 | + | frequency and causes of ad verse incidents to patients, |
---|
| 569 | + | b. the identification of trends or patterns of incidents, |
---|
| 570 | + | c. the development of measures to correct, reduce, |
---|
| 571 | + | minimize or eliminate the risk of adverse incident s to |
---|
| 572 | + | patients, and |
---|
603 | | - | 1. Peace officers certified pursuant to Section 3311 of Title |
---|
604 | | - | 70 of the Oklahoma Statutes who are employed as investigative agents |
---|
605 | | - | of the Oklahoma State Bureau of Narcotics and Dangerous Drugs |
---|
606 | | - | Control; |
---|
607 | | - | 2. The United States Drug Enforcement Administration Diversion |
---|
608 | | - | Group Supervisor; |
---|
609 | | - | 3. The executive director or chief investigator, as designated |
---|
610 | | - | by each board, of the following state boards: |
---|
611 | | - | a. Board of Podiatric Medical Examiners, |
---|
612 | | - | b. Board of Dentistry, |
---|
613 | | - | c. Board of Pharmacy, |
---|
614 | | - | d. State Board of Medical Licensure and Supervision, |
---|
615 | | - | e. State Board of Osteopathic Examiners, |
---|
616 | | - | f. State Board of Veterinary Medical Examiners, |
---|
617 | | - | g. Oklahoma Health Care Authority , |
---|
618 | | - | h. Department of Mental Health and Substance Abuse |
---|
619 | | - | Services, |
---|
620 | | - | i. Board of Examiners in Optometry, |
---|
621 | | - | j. Oklahoma Board of Nursing, |
---|
622 | | - | k. Office of the Chief Medical Examiner, and |
---|
623 | | - | l. State Board of Health; |
---|
624 | | - | 4. A multicounty grand jury properly convened pursuant to the |
---|
625 | | - | Multicounty Grand Jury Act; |
---|
| 599 | + | d. the documentation of these functions and perio dic |
---|
| 600 | + | review no less than quarterly of such information by |
---|
| 601 | + | the designated physician. |
---|
| 602 | + | J. The designated physician is responsible for ensuring |
---|
| 603 | + | compliance with the following data collection an d reporting |
---|
| 604 | + | requirements: |
---|
| 605 | + | 1. The designated physician for each pain management clinic |
---|
| 606 | + | shall report all adverse incidents to the State Board of Medical |
---|
| 607 | + | Licensure and Supervision; and |
---|
| 608 | + | 2. The designated physician shall also report to the State |
---|
| 609 | + | Board of Medical Licensure and Supervision, in writing, on a |
---|
| 610 | + | quarterly basis the following data: |
---|
| 611 | + | a. the number of new and repeat patients seen and treated |
---|
| 612 | + | at the clinic who are prescribed controlled dangerous |
---|
| 613 | + | substance medications for the treatment of chronic, |
---|
| 614 | + | nonmalignant pain, |
---|
| 615 | + | b. the number of patients discharged due to drug abuse, |
---|
| 616 | + | c. the number of patients discharged due to drug |
---|
| 617 | + | diversion, and |
---|
| 618 | + | d. the number of patients treated at the clinic whose |
---|
| 619 | + | domicile is located somewhere other than in this |
---|
| 620 | + | state. A patient’s do micile is the patient’s fixed or |
---|
| 621 | + | permanent home to which he or she i ntends to return |
---|
652 | | - | 5. Medical practitioners employ ed by the United States |
---|
653 | | - | Department of Veterans Affairs, the United States Military, or other |
---|
654 | | - | federal agencies treating patients in this state; |
---|
655 | | - | 6. At the discretion of the Director of the Oklahoma State |
---|
656 | | - | Bureau of Narcotics and Dangerous Drugs Control, medi cal |
---|
657 | | - | practitioners and their staff including those employed by the |
---|
658 | | - | federal government in this state; and |
---|
659 | | - | 7. The members of the Opioid Overdose Fatality Review Board for |
---|
660 | | - | the purpose of carrying out the duties prescribed by Section 2 -1001 |
---|
661 | | - | of this title. |
---|
662 | | - | B. This section shall not prevent access, at the discretion of |
---|
663 | | - | the Director of the Oklahoma State Bureau of Narcotics and Dangerous |
---|
664 | | - | Drugs Control, to investigative information by peace of ficers and |
---|
665 | | - | investigative agents of federal, state, tribal, county or mun icipal |
---|
666 | | - | law enforcement agencies, district attorneys and the Attorney |
---|
667 | | - | General in furtherance of criminal, civil or administrative |
---|
668 | | - | investigations or prosecutions within their respective |
---|
669 | | - | jurisdictions, designat ed legal, communications, and analytical |
---|
670 | | - | employees of the Bureau, and to registrants in furtherance of |
---|
671 | | - | efforts to guard against the diversion of controlled dangerous |
---|
672 | | - | substances. |
---|
673 | | - | C. This section shall not prevent the disclosure, at t he |
---|
674 | | - | discretion of the Di rector of the Oklahoma State Bureau of Narcotics |
---|
675 | | - | and Dangerous Drugs Control, of statistical information gathered |
---|
| 648 | + | even though he or she may temporarily reside |
---|
| 649 | + | elsewhere. |
---|
| 650 | + | K. The data and reports specified in subsection J of this |
---|
| 651 | + | section shall be accessible to the Oklahoma State Bureau of |
---|
| 652 | + | Narcotics and Dangerous Drugs Control. |
---|
| 653 | + | SECTION 4. NEW LAW A new section of law to be codified |
---|
| 654 | + | in the Oklahoma Statutes as Section 2 -1104 of Title 63, unless there |
---|
| 655 | + | is created a duplication in numbering, reads as follows: |
---|
| 656 | + | A. The State Board of Medical Licensure and Supervision may |
---|
| 657 | + | impose an administrative fine on a clinic of up to Five Thousand |
---|
| 658 | + | Dollars ($5,000.00) per violation for violating the requirements of |
---|
| 659 | + | this act or the rules of the State Board of Medical Licensure and |
---|
| 660 | + | Supervision. In determining whether a penalty is to be imposed, and |
---|
| 661 | + | in fixing the amount of the fine, the State Board of Medical |
---|
| 662 | + | Licensure and Supervision shall consider the following factors: |
---|
| 663 | + | 1. The gravity of the violation, including the probability that |
---|
| 664 | + | death or serious physical or emotional harm to a patient has |
---|
| 665 | + | resulted, or could have resulted, from the pain management clinic’s |
---|
| 666 | + | actions or the actions of the physician, the severity of the action |
---|
| 667 | + | or potential harm and the extent to which the provisions of the |
---|
| 668 | + | applicable laws or rules were violated; |
---|
| 669 | + | 2. What actions, if any , the owner or designated physician took |
---|
| 670 | + | to correct the violations; |
---|
702 | | - | from the central repository to the general public for statistical, |
---|
703 | | - | research, substance abuse prevention, or educational purposes, |
---|
704 | | - | provided that consumer confidentiality is not compromised. |
---|
705 | | - | D. This section shall not prevent the disclosure, at the |
---|
706 | | - | discretion of the Director of the Oklahoma State Bureau of Narcotics |
---|
707 | | - | and Dangerous Drugs Control, of prescription -monitoring-program |
---|
708 | | - | information to prescription-monitoring programs of other states |
---|
709 | | - | provided a reciprocal data-sharing agreement is in place. |
---|
710 | | - | E. The Department of Mental Health and Substance Abuse Services |
---|
711 | | - | and the State Department of Health may utilize the information i n |
---|
712 | | - | the central repositor y for statistical, research, substance abuse |
---|
713 | | - | prevention, or educational purposes, provided that consumer |
---|
714 | | - | confidentiality is not compromised. |
---|
715 | | - | F. Any unauthorized disclosure of any information collected at |
---|
716 | | - | the central repository provi ded by the Anti-Drug Diversion Act shall |
---|
717 | | - | be a misdemeanor. Violation of the provisions of this section shall |
---|
718 | | - | be deemed willful neglect of duty and shall be grounds for removal |
---|
719 | | - | from office. |
---|
720 | | - | G. 1. Registrants shall have access to the central repository |
---|
721 | | - | for the purposes of patie nt treatment and to aid in the |
---|
722 | | - | determination in prescribing or screening new patients. The |
---|
723 | | - | physician or designee shall provide, upon request by the patient, |
---|
724 | | - | the history of the patient or the query history of the patient. |
---|
| 697 | + | 3. Whether there were any previous violations at the pain |
---|
| 698 | + | management clinic; and |
---|
| 699 | + | 4. The financial benefits that the pa in management clinic |
---|
| 700 | + | derived from committing or continuing to commit the violation. |
---|
| 701 | + | B. Each day a violation continues after the date fixed for |
---|
| 702 | + | termination of the violation as ordered by the State Board of |
---|
| 703 | + | Medical Licensure and Supervision constitutes an a dditional, |
---|
| 704 | + | separate and distinct violation. |
---|
| 705 | + | C. The State Board of M edical Licensure and Supervision may |
---|
| 706 | + | impose a fine and, in the case of an owner -operated pain management |
---|
| 707 | + | clinic, revoke or deny a pain management clinic’s registration if |
---|
| 708 | + | the clinic’s designated physician knowingly and intentionally |
---|
| 709 | + | misrepresents actions t aken to correct a violation. |
---|
| 710 | + | D. An owner or designated physician of a pain management clinic |
---|
| 711 | + | who concurrently operates an unregistered pain management clinic is |
---|
| 712 | + | subject to an administrati ve fine of Five Thousand Dollars |
---|
| 713 | + | ($5,000.00) per day. |
---|
| 714 | + | E. If the owner of a pain management clinic that requires |
---|
| 715 | + | registration fails to apply to register the clinic upon a change of |
---|
| 716 | + | ownership and operates the clinic under the new ownership, the owner |
---|
| 717 | + | is subject to a fine of Five Thousand Dollars ($5,000.00). |
---|
| 718 | + | SECTION 5. NEW LAW A new section of law to be codified |
---|
| 719 | + | in the Oklahoma Statutes as Section 2 -1105 of Title 63, unless there |
---|
| 720 | + | is created a duplication in numbering, reads as follows : |
---|
751 | | - | 2. a. Prior to prescribing or auth orizing for refill, if one |
---|
752 | | - | hundred eighty (180) d ays have elapsed prior to the |
---|
753 | | - | previous access and check, of opiates, synthetic |
---|
754 | | - | opiates, semisynthetic opiates, benzodiazepine or |
---|
755 | | - | carisoprodol to a patient of record, registrants or |
---|
756 | | - | members of their medical o r administrative staff shall |
---|
757 | | - | be required to acces s the information in the central |
---|
758 | | - | repository to assess medical necessity and the |
---|
759 | | - | possibility that the patient may be unlawfully |
---|
760 | | - | obtaining prescription drugs in violation of the |
---|
761 | | - | Uniform Controlled Dangerous Su bstances Act. The duty |
---|
762 | | - | to access and check shall not alter or otherwise amend |
---|
763 | | - | appropriate medical standards of care. The registrant |
---|
764 | | - | or medical provider shall note in the patient file |
---|
765 | | - | that the central repository has been checked and may |
---|
766 | | - | maintain a copy of the information. |
---|
767 | | - | b. The requirements set forth i n subparagraph a of this |
---|
768 | | - | paragraph shall not apply: |
---|
769 | | - | (1) to medical practitioners who prescribe the |
---|
770 | | - | controlled substances set forth in subparagraph a |
---|
771 | | - | of this paragraph for hospice or en d-of-life |
---|
772 | | - | care, or |
---|
773 | | - | (2) for a prescription of a controlled substance set |
---|
774 | | - | forth in subparagraph a of this paragraph that is |
---|
| 747 | + | All affected agencies and boards shall promulgate such rules as |
---|
| 748 | + | are necessary to implement the provisions of this act. |
---|
| 749 | + | SECTION 6. This act shall become effective November 1, 2021. " |
---|
| 750 | + | Passed the House of Representatives the 28th day of April, 2022. |
---|
801 | | - | issued by a practitioner for a patient residing |
---|
802 | | - | in a nursing facility as defined by Section 1 - |
---|
803 | | - | 1902 of this title, provided that the |
---|
804 | | - | prescription is issued to a resident of such |
---|
805 | | - | facility. |
---|
806 | | - | 3. Registrants shall not be liable to any person for any claim |
---|
807 | | - | of damages as a result of accessing or failing to access the |
---|
808 | | - | information in the central repository and no lawsuit may be |
---|
809 | | - | predicated thereon. |
---|
810 | | - | 4. The failure of a registrant to access and check the central |
---|
811 | | - | repository as required under state or federal law or regulation may, |
---|
812 | | - | after investigation, be grounds for the licensing board of the |
---|
813 | | - | registrant to take disciplinary action against the registr ant. |
---|
814 | | - | H. The Board of Podiatric Medical Examiners, the Board of |
---|
815 | | - | Dentistry, the State Board of Medical Licensure and Supervision, the |
---|
816 | | - | Board of Examiners in Optometry, the Oklahoma Board of Nursing, the |
---|
817 | | - | State Board of Osteopathic Examiners and the State Boar d of |
---|
818 | | - | Veterinary Medical Examiners shall have the sole responsibility for |
---|
819 | | - | enforcement of the provisions of subsection G of this section. |
---|
820 | | - | Nothing in this section shall be construed so as to permit the |
---|
821 | | - | Director of the State Bureau of Narcotics and Dangerous Drugs |
---|
822 | | - | Control to assess administrative fines provided for in Section 2 -304 |
---|
823 | | - | of this title. |
---|
| 794 | + | ENGROSSED SENATE |
---|
| 795 | + | BILL NO. 888 By: Standridge of the Senate |
---|
825 | | - | Req. No. 3952 Page 17 1 |
---|
| 797 | + | and |
---|
| 798 | + | |
---|
| 799 | + | Echols of the House |
---|
| 800 | + | |
---|
| 801 | + | |
---|
| 802 | + | |
---|
| 803 | + | |
---|
| 804 | + | An Act relating to controlled dangerous substances; |
---|
| 805 | + | defining terms; requiring pain management clinics to |
---|
| 806 | + | register with State Board of Medical Licensure and |
---|
| 807 | + | Supervision; providing exemptions; stipulating |
---|
| 808 | + | registration procedures; requiring clinics to |
---|
| 809 | + | designate physician; stipulating procedures for |
---|
| 810 | + | revocation and suspension of registration; limiting |
---|
| 811 | + | period of suspension; requiring new registration |
---|
| 812 | + | application if clinic changes ownership; specifying |
---|
| 813 | + | physician responsibilities; providing facility and |
---|
| 814 | + | physical operations requirements; stipulating certain |
---|
| 815 | + | infection control requirements; providing health and |
---|
| 816 | + | safety requirements; providing certain quality |
---|
| 817 | + | assurance requirements; stipulating certain data |
---|
| 818 | + | collection and reporting requirements; providing that |
---|
| 819 | + | designated physician is responsible for ensuring |
---|
| 820 | + | compliance with all requirements; providing |
---|
| 821 | + | penalties; directing promulgation of rules; amending |
---|
| 822 | + | 59 O.S. 2011, Section 355.1, as amended by Section |
---|
| 823 | + | 21, Chapter 230, O.S.L. 2015 (59 O.S. Supp. 2020, |
---|
| 824 | + | Section 355.1), which relates to dispensation of |
---|
| 825 | + | dangerous drugs; provi ding certain limitations on |
---|
| 826 | + | dispensation of controlled dangerous substances; |
---|
| 827 | + | providing exception; providing for codification; and |
---|
| 828 | + | providing an effective date . |
---|
| 829 | + | |
---|
| 830 | + | |
---|
| 831 | + | |
---|
| 832 | + | |
---|
| 833 | + | |
---|
| 834 | + | BE IT ENACTED BY THE PEOPLE OF THE STATE O F OKLAHOMA: |
---|
| 835 | + | SECTION 7. NEW LAW A new section of law to be codi fied |
---|
| 836 | + | in the Oklahoma Statutes as Section 2 -1101 of Title 63, unless there |
---|
| 837 | + | is created a duplication in numbering, reads as follows: |
---|
| 838 | + | |
---|
| 839 | + | ENGR. S. B. NO. 888 Page 2 1 |
---|
850 | | - | I. The Director of the Oklahoma State Bureau of Narcotics and |
---|
851 | | - | Dangerous Drugs Control, or a designee thereof, shall provide a |
---|
852 | | - | monthly list to the Directors of the Board of Podiatric Medica l |
---|
853 | | - | Examiners, the Board of Dentistry, the State Bo ard of Medical |
---|
854 | | - | Licensure and Supervision, the Board of Examiners in Optometry, the |
---|
855 | | - | Oklahoma Board of Nursing, the State Board of Osteopathic Examiners |
---|
856 | | - | and the State Board of Veterinary Medical Examiners of t he top |
---|
857 | | - | twenty prescribers of controlled dangerous substances within their |
---|
858 | | - | respective areas of jurisdiction. Upon discovering that a |
---|
859 | | - | registrant is prescribing outside the limitations of his or her |
---|
860 | | - | licensure or outside of drug registr ation rules or applicab le state |
---|
861 | | - | laws, the respective licensing board sha ll be notified by the Bureau |
---|
862 | | - | in writing. Such notifications may be considered complaints for the |
---|
863 | | - | purpose of investigations or other actions by the respective |
---|
864 | | - | licensing board. Licensi ng boards shall have ex clusive jurisdiction |
---|
865 | | - | to take action against a lic ensee for a violation of subsection G of |
---|
866 | | - | this section. |
---|
867 | | - | J. Information regarding fatal and nonfatal overdoses, other |
---|
868 | | - | than statistical information as required by Section 2 -106 of this |
---|
869 | | - | title, shall be complete ly confidential. Access to this information |
---|
870 | | - | shall be strictly limited to the Director of the Oklahoma State |
---|
871 | | - | Bureau of Narcotics and Dangerous Drugs Control or designee, the |
---|
872 | | - | Chief Medical Examiner, state agencies and boards provided in |
---|
873 | | - | subsection A of this section, and the registrant that enters the |
---|
| 864 | + | As used in this act: |
---|
| 865 | + | 1. “Board eligible” means successful completion of an |
---|
| 866 | + | anesthesia, physical medicine and rehabilitation, rheumatology or |
---|
| 867 | + | neurology residency program approved by the Accreditation Council |
---|
| 868 | + | for Graduate Medical Education or the American Osteopathic |
---|
| 869 | + | Association for a period of six (6) years from successful completion |
---|
| 870 | + | of such residency program; |
---|
| 871 | + | 2. “Chronic nonmalignant pain” means pain unrelated to cancer |
---|
| 872 | + | which persists beyond the usual course of disease or the injury that |
---|
| 873 | + | is the cause of the pain or more than ninety (90) calend ar days |
---|
| 874 | + | after surgery; and |
---|
| 875 | + | 3. “Pain management clinic” or “clinic” means any publicly or |
---|
| 876 | + | privately owned facility: |
---|
| 877 | + | a. that advertises in any m edium for any type of pain |
---|
| 878 | + | management services, or |
---|
| 879 | + | b. where in any month a majority of patients are |
---|
| 880 | + | prescribed opioids, benzodiazepines, barbiturates or |
---|
| 881 | + | carisoprodol for the treatment of chronic nonm alignant |
---|
| 882 | + | pain. |
---|
| 883 | + | SECTION 8. NEW LAW A new section of law to be codified |
---|
| 884 | + | in the Oklahoma Statutes as Section 2 -1102 of Title 63, unless there |
---|
| 885 | + | is created a duplication in numbering, reads as f ollows: |
---|
| 886 | + | A. Each pain management clinic shall register with the State |
---|
| 887 | + | Board of Medical Licensure and Supervision unless: |
---|
900 | | - | information. Registrants shall not be liable to any person for a |
---|
901 | | - | claim of damages for information reported pursuant to the provisions |
---|
902 | | - | of Section 2-105 of this title. |
---|
903 | | - | K. The Director of t he Oklahoma State Burea u of Narcotics and |
---|
904 | | - | Dangerous Drugs Control shall provide adequate means and procedures |
---|
905 | | - | allowing access to central repository information for registrants |
---|
906 | | - | lacking direct computer access. |
---|
907 | | - | L. Upon completion of an investigation in which it is |
---|
908 | | - | determined that a death was caused by an overdose, either |
---|
909 | | - | intentionally or unintentionally, of a controlled dangerous |
---|
910 | | - | substance, the medical examiner shall be required to report the |
---|
911 | | - | decedent’s name and date of birth to the Oklahoma State Bureau of |
---|
912 | | - | Narcotics and Dangerous Drugs Control. The Oklahoma State Bureau of |
---|
913 | | - | Narcotics and Dangerous Drugs Control shall be required to maintain |
---|
914 | | - | a database containing the classification of medical practitioners |
---|
915 | | - | who prescribed or authorized controlled dangerous subs tances |
---|
916 | | - | pursuant to this subsection. |
---|
917 | | - | M. The Oklahoma State Bureau of Nar cotics and Dangerous Drugs |
---|
918 | | - | Control is authorized to provide unsolicited notification to the |
---|
919 | | - | licensing board of a pharmacist or practitioner if a patient has |
---|
920 | | - | received one or more prescriptions for controlled substances in |
---|
921 | | - | quantities or with a frequency inco nsistent with generally |
---|
922 | | - | recognized standards of safe practice. An unsolicited notification |
---|
923 | | - | to the licensing board of the practitioner pursuant to this section: |
---|
| 914 | + | 1. The majority of the physicians who provide services in the |
---|
| 915 | + | clinic primarily provide s urgical services; |
---|
| 916 | + | 2. The clinic is owned by a publicly held corporation whose |
---|
| 917 | + | shares are traded on a national exchange or on the over -the-counter |
---|
| 918 | + | market and whose total assets at the end of the corporation ’s most |
---|
| 919 | + | recent fiscal quarter exceeded Fifty Milli on Dollars |
---|
| 920 | + | ($50,000,000.00); |
---|
| 921 | + | 3. The clinic is affiliated with an accredited medical schoo l |
---|
| 922 | + | at which training is provided for medical students, res idents or |
---|
| 923 | + | fellows; |
---|
| 924 | + | 4. The clinic does not prescribe controlled dangerous |
---|
| 925 | + | substances for the treatment of pai n; |
---|
| 926 | + | 5. The clinic is owned by a corporate enti ty exempt from |
---|
| 927 | + | federal taxation under 26 U.S .C., Section 501(c)(3) (1954); |
---|
| 928 | + | 6. The clinic is wholly o wned and operated by one or more |
---|
| 929 | + | board-eligible or board-certified anesthesiologists, physiatrists, |
---|
| 930 | + | rheumatologists or neurologists; or |
---|
| 931 | + | 7. The clinic is wholly owned and operated by a physician |
---|
| 932 | + | multispecialty practice where one or more board -eligible or board- |
---|
| 933 | + | certified medical specialists, who have also completed fellowships |
---|
| 934 | + | in pain medicine approved by the Accr editation Council for Graduate |
---|
| 935 | + | Medical Education or who are also certified in pain medicin e by the |
---|
| 936 | + | American Board of Pain Medicine or a board appro ved by the American |
---|
| 937 | + | Board of Medical Specialties, the American Association of Physician |
---|
950 | | - | 1. Is confidential; |
---|
951 | | - | 2. May not disclose info rmation that is confidential pursuant |
---|
952 | | - | to this section; and |
---|
953 | | - | 3. May be in a summary form sufficient to provide notice of the |
---|
954 | | - | basis for the unsolicited notification. |
---|
955 | | - | N. Except as otherwise provided for in subsections A and B of |
---|
956 | | - | this section, any information collected at the central repository, |
---|
957 | | - | as outlined in Section 2-309C of this title, shall: |
---|
958 | | - | 1. Be confidential by law and privileged; |
---|
959 | | - | 2. Not be subject to the Oklahoma Open Records Act; |
---|
960 | | - | 3. Not be subject to subpoena; and |
---|
961 | | - | 4. Not be subject to discovery or admissible in evidence in any |
---|
962 | | - | private civil action. |
---|
963 | | - | O. Beginning January 1, 2024, upon receipt of a report from the |
---|
964 | | - | Chief Medical Examiner in which the cause of death or a contributing |
---|
965 | | - | factor to the death was determined to be one or more opioid drugs as |
---|
966 | | - | described in subsection B of Section 9 42 of this title, the Oklahoma |
---|
967 | | - | State Bureau of Narcotics and Dangerous Drugs Control shall search |
---|
968 | | - | the decedent in the central repository to determine if the decedent |
---|
969 | | - | had been prescribed one or more opioid drugs at any point in the |
---|
970 | | - | year prior to the death. Beginning January 1, 2024, if the Bureau |
---|
971 | | - | determines that the decedent had been prescribed one or more opioid |
---|
972 | | - | drugs at any point in the year prior to the death, the Bureau may |
---|
973 | | - | report the name of the prescribing practit ioner to the |
---|
| 964 | + | Specialists or the Am erican Osteopathic Association, perform |
---|
| 965 | + | interventional pain procedures of the type routine ly billed using |
---|
| 966 | + | surgical codes. |
---|
| 967 | + | B. Each clinic location shall be registered separately |
---|
| 968 | + | regardless of whether the clinic is operated under the same business |
---|
| 969 | + | name or management as another clinic. |
---|
| 970 | + | C. As a part of registration, a clinic shall designate a |
---|
| 971 | + | physician who is responsible for complying with all requirem ents |
---|
| 972 | + | related to registration and operation of the clinic in compliance |
---|
| 973 | + | with this act. Within ten (10) calend ar days after termination of a |
---|
| 974 | + | designated physician, the clinic shall notify the State Board of |
---|
| 975 | + | Medical Licensure and Supervision of the identity o f another |
---|
| 976 | + | designated physician for that clinic. The designated physician |
---|
| 977 | + | shall have a full, active and unenc umbered license pursuant to |
---|
| 978 | + | Section 480 et seq. or Section 620 et seq. of Title 59 of the |
---|
| 979 | + | Oklahoma Statutes and shall practice at the clinic locati on for |
---|
| 980 | + | which the physician has assumed responsibility. Failing to have a |
---|
| 981 | + | licensed designated physician pract icing at the location of the |
---|
| 982 | + | registered clinic may be the basis for a summary suspension o f the |
---|
| 983 | + | clinic registration certificate as described in thi s section. |
---|
| 984 | + | D. The State Board of Medical Licensure and Supervision shall |
---|
| 985 | + | deny registration to any clinic tha t is not fully owned by a |
---|
| 986 | + | physician licensed p ursuant to Section 480 et seq. or Section 62 0 et |
---|
| 987 | + | seq. of Title 59 of the Oklahoma Statutes or group o f physicians, |
---|
1000 | | - | practitioner’s licensing board an d may report any other information |
---|
1001 | | - | from the central repository requested by the licensing board |
---|
1002 | | - | pertaining to the death for the purposes of investigation by the |
---|
1003 | | - | licensing board. |
---|
1004 | | - | SECTION 3. NEW LAW A new section of law to be codified |
---|
1005 | | - | in the Oklahoma Statutes as Section 2-312.3 of Title 63, unless |
---|
1006 | | - | there is created a duplica tion in numbering, reads as follows: |
---|
1007 | | - | Any licensed practitioner as defined in Section 353.1 of Title |
---|
1008 | | - | 59 of the Oklahoma Statutes other than a veterinarian , or any health |
---|
1009 | | - | care provider other than a licensed practitioner, who has the |
---|
1010 | | - | authority to prescribe , dispense, or administer any controlled |
---|
1011 | | - | dangerous substance under Section 2-312 of Title 63 of the Oklahoma |
---|
1012 | | - | Statutes, or his or her employer on his or her behalf, shall carry |
---|
1013 | | - | malpractice insurance or demonstrate proof of financial |
---|
1014 | | - | responsibility in a minimum amount of One Million Dollars |
---|
1015 | | - | ($1,000,000.00) per occurrence and Three Millio n Dollars |
---|
1016 | | - | ($3,000,000.00) in the aggregate per year. |
---|
1017 | | - | SECTION 4. NEW LAW A new section of law to be codified |
---|
1018 | | - | in the Oklahoma Statutes as Section 2 -1102 of Title 63, unless there |
---|
1019 | | - | is created a duplication in numbering, reads as follows: |
---|
1020 | | - | As used in this act: |
---|
1021 | | - | 1. "Chronic nonmalignant pain" means pain unrelated to cancer |
---|
1022 | | - | which persists beyond the usual course of disease or the injury that |
---|
| 1014 | + | each of whom is licensed pursuant to Section 480 et seq. or Section |
---|
| 1015 | + | 620 et seq. of Title 59 of the Oklahoma Statutes. |
---|
| 1016 | + | E. The State Board of Medical Licensure and Supervision shall |
---|
| 1017 | + | deny registration to any pain management clinic owned by or w ith any |
---|
| 1018 | + | contractual or employment relationship with a physician: |
---|
| 1019 | + | 1. Whose Drug Enforcement Administration nu mber has ever been |
---|
| 1020 | + | revoked; |
---|
| 1021 | + | 2. Whose application for a license to prescribe, dispense or |
---|
| 1022 | + | administer a controlled substance has been denied by any |
---|
| 1023 | + | jurisdiction; |
---|
| 1024 | + | 3. Who has been convicted of or pleaded guilty or nolo |
---|
| 1025 | + | contendere to, regardless of adjudicati on, an offense that |
---|
| 1026 | + | constitutes a felony for r eceipt of illicit or diverted drugs, |
---|
| 1027 | + | including a controlled substance listed in Schedule I, II, III, IV |
---|
| 1028 | + | or V of the Uniform Controlled Dangerous Substances Act, in this |
---|
| 1029 | + | state, any other state or the United Stat es. |
---|
| 1030 | + | F. If the State Board of Medical Licensur e and Supervision |
---|
| 1031 | + | finds that a pain management clinic does not meet the requirement of |
---|
| 1032 | + | subsection D of this section or is owned, directly or indirectly, by |
---|
| 1033 | + | a person meeting any criteria listed in subsection E o f this |
---|
| 1034 | + | section, the State Board of Medical Lic ensure and Supervision shall |
---|
| 1035 | + | revoke the certificate of registration previously issued by the |
---|
| 1036 | + | State Board of Medical Licensure and Supervision. As determined by |
---|
| 1037 | + | rule, the State Board of Medical Licensure and Supervision may grant |
---|
1049 | | - | is the cause of the pain or more than ninety (90) calendar days |
---|
1050 | | - | after surgery; |
---|
1051 | | - | 2. “Licensed prescriber” means a licensed practitioner as |
---|
1052 | | - | defined in Section 353.1 of Title 59 of the Oklahoma Statutes other |
---|
1053 | | - | than a veterinarian, or any health care provider other than a |
---|
1054 | | - | licensed practitioner, who has the authority to prescribe any |
---|
1055 | | - | controlled dangerous s ubstance under Section 2 -312 of Title 63 of |
---|
1056 | | - | the Oklahoma Statutes; and |
---|
1057 | | - | 3. "Pain management clinic" or "clinic" means any publicly or |
---|
1058 | | - | privately owned facility: |
---|
1059 | | - | a. that engages in significant paid advertising in any |
---|
1060 | | - | medium for any type of pain management services, and |
---|
1061 | | - | b. where in any month over sixty percent (60%) of |
---|
1062 | | - | patients who are not being seen for hospice or |
---|
1063 | | - | palliative care are prescribed opioids, |
---|
1064 | | - | benzodiazepines, barbiturates , or carisoprodol for the |
---|
1065 | | - | treatment of chronic nonmalignant pain. |
---|
1066 | | - | SECTION 5. NEW LAW A ne w section of law to be codified |
---|
1067 | | - | in the Oklahoma Statutes as Section 2-1103 of Title 63, unless there |
---|
1068 | | - | is created a duplication in numbering, reads as follows: |
---|
1069 | | - | A. Each pain management clinic shall register with the Oklahoma |
---|
1070 | | - | State Bureau of Narcotics and Dangerous Drugs Control unless: |
---|
| 1064 | + | an exemption to denying a registration or revoking a previously |
---|
| 1065 | + | issued registration if more than ten (10) years have elapsed si nce |
---|
| 1066 | + | adjudication. As used in this section, the term “convicted” |
---|
| 1067 | + | includes an adjudication of guilt following a plea of guilty or nolo |
---|
| 1068 | + | contendere or the for feiture of a bond when charged with a crime. |
---|
| 1069 | + | G. If the registration of a pain management clinic is revoked |
---|
| 1070 | + | or suspended, the designated physician of the pain management |
---|
| 1071 | + | clinic, the owner or lessor of the pain management clinic property, |
---|
| 1072 | + | the manager and the proprietor shall cease to operate the faci lity |
---|
| 1073 | + | as a pain management clinic as of the effective date of the |
---|
| 1074 | + | suspension or revocation. |
---|
| 1075 | + | H. If a pain management clinic registration is revoked or |
---|
| 1076 | + | suspended, the designated physician of the pain management clinic, |
---|
| 1077 | + | the owner or lessor of the clinic prope rty, the manager or the |
---|
| 1078 | + | proprietor is responsible for rem oving all signs and symbols |
---|
| 1079 | + | identifying the premises as a pain management clinic. |
---|
| 1080 | + | I. If the clinic’s registration is revoked, any person named in |
---|
| 1081 | + | the registration documents of the pain management clinic, including |
---|
| 1082 | + | persons owning or operating the pain management clinic, shall not, |
---|
| 1083 | + | as an individual or as a part of a group, apply to operate a pain |
---|
| 1084 | + | management clinic for five (5) years after the date the registr ation |
---|
| 1085 | + | is revoked. |
---|
1097 | | - | 1. The clinic is affiliated wi th an accredited medical school |
---|
1098 | | - | at which training is provided for medical students, residents , or |
---|
1099 | | - | fellows; |
---|
1100 | | - | 2. The clinic does not prescribe controlled dangerous |
---|
1101 | | - | substances for the treatment of pain; |
---|
1102 | | - | 3. The clinic primarily treats hospice or palliative ca re |
---|
1103 | | - | patients; or |
---|
1104 | | - | 4. A majority of the patients treated by the clinic are treated |
---|
1105 | | - | for acute pain. |
---|
1106 | | - | B. Each clinic location shall be registered separately |
---|
1107 | | - | regardless of whether the clinic is operated under the same business |
---|
1108 | | - | name or management as another cl inic and each clinic location shall |
---|
1109 | | - | be a permanent, fixed, physical address of operation . |
---|
1110 | | - | C. As a part of registration, a clinic shall designate a n owner |
---|
1111 | | - | or administrator who is responsible for ensuring compliance with all |
---|
1112 | | - | requirements related to registrati on and operation of the clinic |
---|
1113 | | - | under this act. Within ten (10) calendar days after terminati on of |
---|
1114 | | - | a designated administrator, the clinic shall notify the Bureau of |
---|
1115 | | - | the identity of another designated administrator for that clinic. |
---|
1116 | | - | Failing to have a designated administrator at the location of the |
---|
1117 | | - | registered clinic may be the basis for a summary suspension o f the |
---|
1118 | | - | clinic registration certificate as d escribed in this section. |
---|
| 1112 | + | J. The period of suspensi on for the registration of a pain |
---|
| 1113 | + | management clinic shall be prescribed by the State Board of Medical |
---|
| 1114 | + | Licensure and Supervision but shall not exceed one (1) year. |
---|
| 1115 | + | K. A change of ownership of a registered pain management clinic |
---|
| 1116 | + | requires submission of a new registration application. |
---|
| 1117 | + | SECTION 9. NEW LAW A new section of law to be codified |
---|
| 1118 | + | in the Oklahoma Statutes as Section 2 -1103 of Title 63, unl ess there |
---|
| 1119 | + | is created a duplication in numberin g, reads as follows: |
---|
| 1120 | + | A. A physician shall no t practice medicine in a pain management |
---|
| 1121 | + | clinic if the clinic is not registered with the State Board of |
---|
| 1122 | + | Medical Licensure and Supervision as required by this act. Any |
---|
| 1123 | + | physician who qualifies to practice medicin e in a pain management |
---|
| 1124 | + | clinic pursuant to rul es adopted by the State Board of Medical |
---|
| 1125 | + | Licensure and Supervision may continue to practice medicine in a |
---|
| 1126 | + | pain management clinic as long as the physician continues to mee t |
---|
| 1127 | + | the qualifications prescribed in the rules. A physician who |
---|
| 1128 | + | violates this subsectio n is subject to disciplinary action by his or |
---|
| 1129 | + | her appropriate medical regulatory board. |
---|
| 1130 | + | B. Only a physician licensed pur suant to Section 480 et seq. or |
---|
| 1131 | + | Section 620 et seq. of Title 59 of the Oklahoma Statutes m ay |
---|
| 1132 | + | prescribe a controlled dangerous substance on the premises of a |
---|
| 1133 | + | registered pain management clinic. No person shall dispense any |
---|
| 1134 | + | controlled dangerous substance on the premises of a pain management |
---|
| 1135 | + | clinic. |
---|
1145 | | - | D. The Bureau shall deny registration to any pain management |
---|
1146 | | - | clinic owned by or with any contractual or employment relationship |
---|
1147 | | - | with a licensed prescriber: |
---|
1148 | | - | 1. Whose Drug Enforcement Administration number has ever been |
---|
1149 | | - | revoked; |
---|
1150 | | - | 2. Whose application for a license to prescribe, dispense , or |
---|
1151 | | - | administer a controlled substance has been denied for disciplinary |
---|
1152 | | - | action by the appropriate licensing board; or |
---|
1153 | | - | 3. Who has been convicted of or pleaded guilty or nolo |
---|
1154 | | - | contendere to, regardless of adjudication, an offense that |
---|
1155 | | - | constitutes a felony for receipt of illicit or diverted drugs |
---|
1156 | | - | including a controlled substance listed in Sc hedule I, II, III, IV, |
---|
1157 | | - | or V of the Uniform Controlled Dangerous Substances Act, in this |
---|
1158 | | - | state, any other state , or the United States. |
---|
1159 | | - | E. If the Bureau finds that a pain management clinic is owned, |
---|
1160 | | - | directly or indirectly, by a person meeting any criteria listed in |
---|
1161 | | - | subsection D of this section, the Bureau shall revoke the |
---|
1162 | | - | certificate of registration previously iss ued by the Bureau. As |
---|
1163 | | - | determined by rule, the Bureau may grant an exemption to denying a |
---|
1164 | | - | registration or revoking a previously issued registration if more |
---|
1165 | | - | than five (5) years have elapsed since adjudication. As used in |
---|
1166 | | - | this section, the term "convicted" includes an adjudication of guilt |
---|
1167 | | - | following a plea of guilty or nolo contendere or the forfeiture of a |
---|
1168 | | - | bond when charged with a crime. |
---|
| 1162 | + | C. A physician, a physician assistant or an Advanced Practice |
---|
| 1163 | + | Registered Nurse shall perform a physical examination of a patient |
---|
| 1164 | + | on the same day that the physician prescribes a controlled substance |
---|
| 1165 | + | to a patient at a pain management clinic. If the physician |
---|
| 1166 | + | prescribes more than a seventy -two-hour dose of controlled dangerous |
---|
| 1167 | + | substances for the treatment of chronic nonmalignant pain, the |
---|
| 1168 | + | physician shall document in the patient’s record the reason for |
---|
| 1169 | + | prescribing that quantity. |
---|
| 1170 | + | D. A physician authorized to prescri be controlled dangerous |
---|
| 1171 | + | substances who practices at a pain management clinic is responsible |
---|
| 1172 | + | for maintaining the control and security of his or her prescription |
---|
| 1173 | + | blanks and any other method used for prescribing controlled |
---|
| 1174 | + | dangerous substance pain medication. The physician shall notify, in |
---|
| 1175 | + | writing, the State Board of Medical Licensure and Supervision within |
---|
| 1176 | + | twenty-four (24) hours following any thef t or loss of a prescription |
---|
| 1177 | + | blank or breach of any other method for prescribing pain medication. |
---|
| 1178 | + | E. The designated physician of a pain management clinic shall |
---|
| 1179 | + | notify the applicable board in writing of the date of termination of |
---|
| 1180 | + | employment within ten (10) calendar days after terminating his or |
---|
| 1181 | + | her employment with a pain management clinic that is required to be |
---|
| 1182 | + | registered pursuant to this act. Each physicia n practicing in a |
---|
| 1183 | + | pain management clinic shall advise the State Board of Medical |
---|
| 1184 | + | Licensure and Supervision, in writing, within ten (10) calendar days |
---|
1195 | | - | F. If the registration of a pain man agement clinic is revoked |
---|
1196 | | - | or suspended, the designated administrator of the pain management |
---|
1197 | | - | clinic, the owner or lessor of the pain management clinic property, |
---|
1198 | | - | the manager, and the proprietor shall cea se to operate the facility |
---|
1199 | | - | as a pain management clinic as of the effective date of the |
---|
1200 | | - | suspension or revocation. |
---|
1201 | | - | G. If a pain management clinic registration is revoked or |
---|
1202 | | - | suspended, the designated administrator of the pain management |
---|
1203 | | - | clinic, the owner or lessor of the clinic property, the manager , or |
---|
1204 | | - | the proprietor is responsible for removing all signs and symbols |
---|
1205 | | - | identifying the premises as a pain management clinic. |
---|
1206 | | - | H. If the clinic's registration is revoked, any person named in |
---|
1207 | | - | the registration document s of the pain management clinic including |
---|
1208 | | - | persons owning or oper ating the pain management clinic, s hall not, |
---|
1209 | | - | as an individual or as a part of a group, apply to operate a pain |
---|
1210 | | - | management clinic for one (1) year after the date the registration |
---|
1211 | | - | is revoked. |
---|
1212 | | - | I. The period of suspension for the registration of a pain |
---|
1213 | | - | management clinic shall be prescribed by the Bureau but shall not |
---|
1214 | | - | exceed one (1) year. |
---|
1215 | | - | J. A change of ownership of a registered pain management clinic |
---|
1216 | | - | shall require submission of a new registration application. |
---|
| 1211 | + | after beginning or ending his or her practice at a pain management |
---|
| 1212 | + | clinic. |
---|
| 1213 | + | F. Each physician practicing i n a pain management clinic is |
---|
| 1214 | + | responsible for ensuring compliance with the following facility and |
---|
| 1215 | + | physical operations requirements: |
---|
| 1216 | + | 1. A pain management clinic shall be located and operated at a |
---|
| 1217 | + | publicly accessible fixed location and shall: |
---|
| 1218 | + | a. display a sign that can be viewed by t he public that |
---|
| 1219 | + | contains the clinic name, hours of operation s and a |
---|
| 1220 | + | street address, |
---|
| 1221 | + | b. have a publicly listed telephone number and a |
---|
| 1222 | + | dedicated phone number to send and receive facsimiles |
---|
| 1223 | + | with a facsimile machine that shall be ope rational |
---|
| 1224 | + | twenty-four (24) hours per day, |
---|
| 1225 | + | c. have emergency lighting and communications, |
---|
| 1226 | + | d. have a reception and waiting area, |
---|
| 1227 | + | e. provide a restroom, |
---|
| 1228 | + | f. have an administrative area, including room for |
---|
| 1229 | + | storage of medical records, supplies and equipment, |
---|
| 1230 | + | g. have private patient examina tion rooms, |
---|
| 1231 | + | h. have treatment rooms, if treatment is being provided |
---|
| 1232 | + | to the patients, and |
---|
| 1233 | + | i. display a printed sign located in a conspicuous place |
---|
| 1234 | + | in the waiting room viewable by the public with the |
---|
1243 | | - | SECTION 6. NEW LAW A new section of law to be codified |
---|
1244 | | - | in the Oklahoma Statutes as Section 2-1104 of Title 63, unless there |
---|
1245 | | - | is created a duplication in numbering, reads as follows: |
---|
1246 | | - | A. A licensed prescriber shall not be employed or contracted by |
---|
1247 | | - | or otherwise practice i n a pain management clinic if the clinic is |
---|
1248 | | - | not licensed by the Oklahoma State Bureau of Narcotics and Dangerous |
---|
1249 | | - | Drugs Control under this act and registered with the Bureau under |
---|
1250 | | - | Section 2-301 et seq. of Title 63 of the Oklahoma Statutes. A |
---|
1251 | | - | licensed prescriber who qualifies to practice in a pain management |
---|
1252 | | - | clinic pursuant to rules adopted by the appropriate licensing board |
---|
1253 | | - | may continue to practice in a pain management clinic as long as the |
---|
1254 | | - | licensed prescriber continues to meet the qualifications prescribed |
---|
1255 | | - | in the rules. A licensed prescriber who violates this subsection is |
---|
1256 | | - | subject to disciplinary action by the appropriate licensing board. |
---|
1257 | | - | B. Only a licensed prescriber licensed in this state and |
---|
1258 | | - | authorized to prescribe controlled dangerous substances under |
---|
1259 | | - | Section 2-312 of Title 63 of the Oklahoma Statutes may prescribe a |
---|
1260 | | - | controlled dangerous subst ance on the premises of a reg istered pain |
---|
1261 | | - | management clinic and only to the extent allowed by Section 2-312 of |
---|
1262 | | - | Title 63 of the Oklahoma Statutes . No person shall dispense any |
---|
1263 | | - | controlled dangerous substance on the premises of a pain m anagement |
---|
1264 | | - | clinic. The provisions of this subsection shall not be construed to |
---|
1265 | | - | expand or otherwise modify the prescriptive authority of any |
---|
1266 | | - | licensed prescriber. |
---|
| 1261 | + | name and contact information of the clinic’s |
---|
| 1262 | + | designated physician and the names of all physicians |
---|
| 1263 | + | practicing in the clinic; and |
---|
| 1264 | + | 2. This section does not excuse a physician from providing any |
---|
| 1265 | + | treatment or performing any medical duty without the pr oper |
---|
| 1266 | + | equipment and materials as required by the standard of care. This |
---|
| 1267 | + | section does not supersede the level of care, skill or treatment |
---|
| 1268 | + | recognized in general law related to health care licensure. |
---|
| 1269 | + | G. Each physician practicing in a pain management clinic is |
---|
| 1270 | + | responsible for ensuring compliance wi th the following infection |
---|
| 1271 | + | control requirements: |
---|
| 1272 | + | 1. The clinic shall maintain equipment and supplies t o support |
---|
| 1273 | + | infection prevention and control activities; |
---|
| 1274 | + | 2. The clinic shall identify infection risks based on the |
---|
| 1275 | + | following: |
---|
| 1276 | + | a. geographic location, comm unity and population served , |
---|
| 1277 | + | b. the care, treatment and services it provides, and |
---|
| 1278 | + | c. an analysis of its infection surveillance and control |
---|
| 1279 | + | data; and |
---|
| 1280 | + | 3. The clinic shall maintain written infection prevention |
---|
| 1281 | + | policies and procedures that address the followi ng: |
---|
| 1282 | + | a. prioritized risks, |
---|
| 1283 | + | b. limiting unprotected exposure to pathogens, |
---|
1293 | | - | C. A licensed prescriber shall perform a physical examinatio n |
---|
1294 | | - | of a patient on the same day that t he licensed prescriber prescribes |
---|
1295 | | - | a controlled substance to a patient at a pain management clin ic. |
---|
1296 | | - | D. A licensed prescriber authorized to prescribe controlled |
---|
1297 | | - | dangerous substances who practices at a pain management clinic is |
---|
1298 | | - | responsible for maintaining the control and securi ty of his or her |
---|
1299 | | - | prescription blanks and an y other method used for prescribing |
---|
1300 | | - | controlled dangerous substance pain medication. The licensed |
---|
1301 | | - | prescriber shall notify, in writing, the Bureau within twenty-four |
---|
1302 | | - | (24) hours following any theft or loss of a prescription bl ank or |
---|
1303 | | - | breach of any other method for prescribing pain medication. The |
---|
1304 | | - | provisions of this subsection shall not be construed to exempt a |
---|
1305 | | - | licensed prescriber from any electronic prescription requirements |
---|
1306 | | - | stipulated in Section 2-309 of Title 63 of the Oklahoma Statutes. |
---|
1307 | | - | E. The designated administrator of a pain management clinic |
---|
1308 | | - | shall notify the Bureau in writing of the date of termination of |
---|
1309 | | - | employment within ten (10) calendar days after terminatin g his or |
---|
1310 | | - | her employment with a pain manage ment clinic that is required to be |
---|
1311 | | - | registered pursuant to this act . |
---|
1312 | | - | F. The owners of a pain management clinic are jointly |
---|
1313 | | - | responsible for ensuring compliance with the following faci lity and |
---|
1314 | | - | physical operations requirements: |
---|
1315 | | - | 1. A pain management clinic shall be located and operated at a |
---|
1316 | | - | publicly accessible fixed location and shall: |
---|
| 1310 | + | c. limiting the transmission o f infections associated |
---|
| 1311 | + | with procedures performed in the clinic, and |
---|
| 1312 | + | d. limiting the transmission of infections a ssociated |
---|
| 1313 | + | with the clinic’s use of medical equipment, devices |
---|
| 1314 | + | and supplies. |
---|
| 1315 | + | H. Each physician practicing in a pain management clinic is |
---|
| 1316 | + | responsible for ensuring compliance with the following health and |
---|
| 1317 | + | safety requirements: |
---|
| 1318 | + | 1. The clinic, including its gr ounds, buildings, furniture, |
---|
| 1319 | + | appliances and equipment shall be str ucturally sound, in good |
---|
| 1320 | + | repair, clean and free from health and safety hazard s; |
---|
| 1321 | + | 2. The clinic shall have evacuation procedures in the event of |
---|
| 1322 | + | an emergency, which shall include provisions f or the evacuation of |
---|
| 1323 | + | disabled patients and employees; |
---|
| 1324 | + | 3. The clinic shall have a writ ten facility-specific disaster |
---|
| 1325 | + | plan specifying actions that will be taken in the event of clinic |
---|
| 1326 | + | closure due to unforeseen disasters and shall include provisions for |
---|
| 1327 | + | the protection of medical records; and |
---|
| 1328 | + | 4. Each clinic shall have at l east one employee on the premises |
---|
| 1329 | + | during patient care hours who is certified in basic life support and |
---|
| 1330 | + | is trained in reacting to accidents and medical emergencies until |
---|
| 1331 | + | emergency medical per sonnel arrive. |
---|
| 1332 | + | I. The designated physic ian is responsible for ens uring |
---|
| 1333 | + | compliance with the following quality assurance requirements: |
---|
1343 | | - | a. display a sign that can be viewed b y the public that |
---|
1344 | | - | contains the clinic name, hours of operations , and a |
---|
1345 | | - | street address, |
---|
1346 | | - | b. have a publicly listed telephone number and a |
---|
1347 | | - | dedicated phone number to send and receive facsimiles, |
---|
1348 | | - | c. have a reception and waiting area, |
---|
1349 | | - | d. provide a restroom, |
---|
1350 | | - | e. have private patient examination rooms, |
---|
1351 | | - | f. have treatment rooms, i f treatment is being provided |
---|
1352 | | - | to the patients, and |
---|
1353 | | - | g. display a printed sign loc ated in a conspicuous place |
---|
1354 | | - | in the waiting room viewable by the public with the |
---|
1355 | | - | name and contact information of the clinic's |
---|
1356 | | - | designated administrator and the names of all licensed |
---|
1357 | | - | prescribers practicing in the clinic; and |
---|
1358 | | - | 2. This section does not excuse a licensed prescriber from |
---|
1359 | | - | providing any treatment or performing any medical duty without the |
---|
1360 | | - | proper equipment and materials as required by the standard of care. |
---|
1361 | | - | This section does not supersede the le vel of care, skill, or |
---|
1362 | | - | treatment recognized in general law related to health care |
---|
1363 | | - | licensure. |
---|
1364 | | - | G. Each owner or designated administrator of a pain management |
---|
1365 | | - | clinic is responsible for ensuring compliance with infection |
---|
| 1360 | + | 1. Each pain management clinic shall have an ongoing quality |
---|
| 1361 | + | assurance program that objectively and systematically: |
---|
| 1362 | + | a. monitors and evaluates the quality and app ropriateness |
---|
| 1363 | + | of patient care, |
---|
| 1364 | + | b. evaluates methods to improve patient care, |
---|
| 1365 | + | c. identifies and corrects deficiencies within the |
---|
| 1366 | + | facility, |
---|
| 1367 | + | d. alerts the designated physician to identify and |
---|
| 1368 | + | resolve recurring problems, and |
---|
| 1369 | + | e. provides for opportunities to imp rove the facility’s |
---|
| 1370 | + | performance and to enhance and improve the quality of |
---|
| 1371 | + | care provided to the public; and |
---|
| 1372 | + | 2. The designated physician shall establish a quality assurance |
---|
| 1373 | + | program that includes the following componen ts: |
---|
| 1374 | + | a. the identification, investigation and analysis of the |
---|
| 1375 | + | frequency and causes of a dverse incidents to patients, |
---|
| 1376 | + | b. the identification of tr ends or patterns of incidents, |
---|
| 1377 | + | c. the development of measures to correct, reduce, |
---|
| 1378 | + | minimize or eliminate the risk of adverse incidents to |
---|
| 1379 | + | patients, and |
---|
| 1380 | + | d. the documentation of thes e functions and peri odic |
---|
| 1381 | + | review no less than quarterly of such information by |
---|
| 1382 | + | the designated physician. |
---|
1402 | | - | 1. The designated administrator for each pain management clinic |
---|
1403 | | - | shall report all significant adverse incidents to the Bureau; and |
---|
1404 | | - | 2. The designated administrator shall also report to the |
---|
1405 | | - | Bureau, in writing, on a quarterly basis the following data: |
---|
| 1412 | + | 1. The designated ph ysician for each pain management clinic |
---|
| 1413 | + | shall report all adverse incidents to the State Board of Medical |
---|
| 1414 | + | Licensure and Supervision; and |
---|
| 1415 | + | 2. The designated physician shall also report to the State |
---|
| 1416 | + | Board of Medical Licensure and Supervision, in writing, on a |
---|
| 1417 | + | quarterly basis the following data: |
---|
1442 | | - | state. A patient's domicile is the patient's fixed or |
---|
1443 | | - | permanent home to which he or she intends to return |
---|
1444 | | - | even though he or she may temporarily reside |
---|
1445 | | - | elsewhere. |
---|
1446 | | - | J. The data and reports specified in subsection I of this |
---|
1447 | | - | section shall be accessible to each appropriate licensing board. |
---|
1448 | | - | K. Each pain management clin ic shall establish a written policy |
---|
1449 | | - | and administrative process for transferring care of patients |
---|
1450 | | - | diagnosed with a substance use disorder where appropriate for their |
---|
1451 | | - | continued treatment. Each appropriate licensing board shall issue |
---|
1452 | | - | guidance on best practices to ensure appropriate referral and |
---|
1453 | | - | treatment of patients with a substance use disorder. |
---|
1454 | | - | L. Upon referral by the ap propriate licensing board, the Bureau |
---|
1455 | | - | shall investigate suspected instances of drug diversion involving a |
---|
1456 | | - | pain management clinic. Nothing in this act shall be construed to |
---|
1457 | | - | restrict the appropriate licensing board from conducting its own |
---|
1458 | | - | investigation into instances of suspected drug diversion. |
---|
1459 | | - | SECTION 7. NEW LAW A new sectio n of law to be codified |
---|
1460 | | - | in the Oklahoma Statutes as Section 2-1105 of Title 63, unless there |
---|
| 1457 | + | SECTION 10. NEW LAW A new section of law to be codified |
---|
| 1458 | + | in the Oklahoma Statutes as Section 2 -1104 of Title 63, unless there |
---|
1462 | | - | A. The Oklahoma State Bureau of Narcotics and Dangerous Drugs |
---|
1463 | | - | Control may impose an administrative fine on a clinic of up to One |
---|
1464 | | - | Thousand Dollars ($1,000.00) per violation for violating the |
---|
| 1460 | + | A. The State Board of Medical Lic ensure and Supervision may |
---|
| 1461 | + | impose an administrative fine on a clinic of up to Five Thousand |
---|
| 1462 | + | Dollars ($5,000.00) p er violation for violating the requireme nts of |
---|
| 1463 | + | this act or the rules of the State Board of Medical Licensure and |
---|
| 1464 | + | Supervision. In determining w hether a penalty is to be imposed, and |
---|
| 1465 | + | in fixing the amount of the fine, the State Board of Medical |
---|
| 1466 | + | Licensure and Supervision shall consider the followin g factors: |
---|
| 1467 | + | 1. The gravity of the violation, i ncluding the probability that |
---|
| 1468 | + | death or serious physical o r emotional harm to a patient has |
---|
| 1469 | + | resulted, or could have resulted, from the pain management clinic’s |
---|
| 1470 | + | actions or the actions of the physician, the severi ty of the action |
---|
| 1471 | + | or potential harm and the ext ent to which the provisions of the |
---|
| 1472 | + | applicable laws or rul es were violated; |
---|
| 1473 | + | 2. What actions, if any, the owner or designated physician took |
---|
| 1474 | + | to correct the violations; |
---|
| 1475 | + | 3. Whether there were any previous violati ons at the pain |
---|
| 1476 | + | management clinic; and |
---|
| 1477 | + | 4. The financial benefits that the pain management clinic |
---|
| 1478 | + | derived from committing or continuing to commit the violation. |
---|
| 1479 | + | B. Each day a violation continues after the date fixed for |
---|
| 1480 | + | termination of the violation as ord ered by the State Board of |
---|
1491 | | - | requirements of this act or the rules promulgated by the Bureau to |
---|
1492 | | - | enforce this act. |
---|
1493 | | - | B. Each day a violation continues after the date fixed for |
---|
1494 | | - | termination of the violati on as ordered by the Bureau constitutes an |
---|
1495 | | - | additional, separate, and distinct violation. |
---|
1496 | | - | C. The Bureau may impose a fine and, in the case of an owner - |
---|
1497 | | - | operated pain management clinic, revoke or deny a pain management |
---|
1498 | | - | clinic's registration if the clinic's owner or designated |
---|
1499 | | - | administrator knowingly and intentionally misrepresents actions |
---|
1500 | | - | taken to correct a violation. |
---|
1501 | | - | D. An owner or designated administrator of a pain management |
---|
1502 | | - | clinic who concurren tly operates an unregistered pain management |
---|
1503 | | - | clinic is subject to an administrative fine of One Thousand Dollars |
---|
1504 | | - | ($1,000.00) per day. |
---|
| 1507 | + | Medical Licensure and Supervision constitutes an additional, |
---|
| 1508 | + | separate and distinct violation. |
---|
| 1509 | + | C. The State Board of Medical Licensure and Supervision may |
---|
| 1510 | + | impose a fine and, in the case of an owner-operated pain management |
---|
| 1511 | + | clinic, revoke or deny a pain management clinic’s registration if |
---|
| 1512 | + | the clinic’s designated physician knowingly and intentionally |
---|
| 1513 | + | misrepresents actions taken to correct a violation. |
---|
| 1514 | + | D. An owner or designated physician of a pain management clinic |
---|
| 1515 | + | who concurrently operates an unregistered pain management clinic is |
---|
| 1516 | + | subject to an administrative fine of Five Thousand D ollars |
---|
| 1517 | + | ($5,000.00) per day. |
---|
1541 | | - | SECTION 9. AMENDATORY 63 O.S. 2021, Section 942, is |
---|
1542 | | - | amended to read as follows: |
---|
1543 | | - | Section 942. A. 1. Upon completion of an investigation, the |
---|
1544 | | - | medical examiner shall reduce his or h er findings to writing upon |
---|
1545 | | - | the form supplied to the medical examiner which shall be promptly |
---|
1546 | | - | sent to the Chief Medical Examiner by mail. |
---|
1547 | | - | 2. If the medical examiner finds that the deceased had illicit, |
---|
1548 | | - | prescription or nonprescription drugs in his or her s ystem at the |
---|
1549 | | - | time of death, the medical examiner shall document in his or her |
---|
1550 | | - | findings if the death was: |
---|
1551 | | - | a. a natural or accidental death with drug involvement, |
---|
1552 | | - | b. a homicide by drugs, |
---|
1553 | | - | c. a suicide by drug overdose, or |
---|
1554 | | - | d. a death with drug involvement, but the manner of death |
---|
1555 | | - | could not be determined. |
---|
1556 | | - | 3. A fatality shall not be considered a drug -related death |
---|
1557 | | - | unless the medical examiner dete rmines that the drug or drugs |
---|
1558 | | - | present in the deceased materially contributed to the death. |
---|
1559 | | - | B. Copies of reports shall be furnished by the Chief Medical |
---|
1560 | | - | Examiner to investigating agencies having official interest therein. |
---|
1561 | | - | Copies of reports shall also be f urnished to the spouse of the |
---|
1562 | | - | deceased or any person within one degree of consanguinity of the |
---|
1563 | | - | deceased upon request a nd within five (5) business days of the |
---|
1564 | | - | request once the cause and manner of death have been de termined and |
---|
| 1556 | + | Section 355.1. A. Except as provided for in Section 353.1 et |
---|
| 1557 | + | seq. of this title, only a licensed practitioner may d ispense |
---|
| 1558 | + | dangerous drugs to such practitioner ’s patients, and only for the |
---|
| 1559 | + | expressed purpose of serving t he best interests and promoting the |
---|
| 1560 | + | welfare of such patients. The dangerous drugs shall be dispensed in |
---|
| 1561 | + | an appropriate container to which a label has b een affixed. Such |
---|
| 1562 | + | label shall include the name and office address of the licensed |
---|
| 1563 | + | practitioner, date di spensed, name of patient, directions for |
---|
| 1564 | + | administration, prescription number, the trade or generic name and |
---|
| 1565 | + | the quantity and strength, not meaning ingre dients, of the drug |
---|
| 1566 | + | therein contained; provided , this requirement shall not apply to |
---|
| 1567 | + | compounded medicines. The licensed practitioner shall keep a |
---|
| 1568 | + | suitable book, file or record in which shall be preserved for a |
---|
| 1569 | + | period of not less than five (5) years a reco rd of every dangerous |
---|
| 1570 | + | drug compounded or dispen sed by the licensed practitioner. |
---|
| 1571 | + | B. A prescriber desiring to dispense dangerous drugs pursuant |
---|
| 1572 | + | to this section shall register annually with the appropriate |
---|
| 1573 | + | licensing board as a dispenser, through a regulator y procedure |
---|
| 1574 | + | adopted and prescribed by such lice nsing board. |
---|
| 1575 | + | C. A prescriber who dispenses professional samples to patients |
---|
| 1576 | + | shall be exempt from the requirement of subsection B of this section |
---|
| 1577 | + | if: |
---|
| 1578 | + | 1. The prescriber f urnishes the professional samples to th e |
---|
| 1579 | + | patient in the package provided by the manufa cturer; |
---|
1591 | | - | the death certificate has been issued. Beginning January 1, 2024, |
---|
1592 | | - | the Chief Medical Examiner shall furnish a copy of any report in |
---|
1593 | | - | which the cause of death or a contributing factor to the death was |
---|
1594 | | - | determined to be one or more opioid drugs to the Oklahoma State |
---|
1595 | | - | Bureau of Narcotics and Dangerous Drugs Control for the purpose of |
---|
1596 | | - | implementing the provisions of subsection O of Section 2-309D of |
---|
1597 | | - | this title. |
---|
1598 | | - | SECTION 10. This act shall become effective November 1, 2022. |
---|
| 1606 | + | 2. No charge is made to the patient; and |
---|
| 1607 | + | 3. An appropriate record is entered in the patient ’s chart. |
---|
| 1608 | + | D. This section shall not apply to the services provided |
---|
| 1609 | + | through the State Department of Health, city/county health |
---|
| 1610 | + | departments, or the Department of Mental Health and Substance Abuse |
---|
| 1611 | + | Services. |
---|
| 1612 | + | E. This section shall not apply to organizations and services |
---|
| 1613 | + | incorporated as state or federal tax -exempt charitable no nprofit |
---|
| 1614 | + | entities and/or organizations a nd services receiving all or part of |
---|
| 1615 | + | their operating funds from a local, state or federal governmental |
---|
| 1616 | + | entity; provided, such organizations and services shall comply with |
---|
| 1617 | + | the labeling and recordkeeping requirements se t out in subsection A |
---|
| 1618 | + | of this section. |
---|
| 1619 | + | F. A prescriber who issues a prescription for a controlled |
---|
| 1620 | + | dangerous substance shall not dispense the controlled dangerous |
---|
| 1621 | + | substance pursuant to such prescription. A prescriber shall not |
---|
| 1622 | + | dispense a controlled danger ous substance pursuant to a prescriptio n |
---|
| 1623 | + | issued by another prescriber if the dispensin g prescriber has a |
---|
| 1624 | + | financial interest in the practice of the prescribing prescriber. |
---|
| 1625 | + | The restrictions on dispensing of controlled dangerous substances |
---|
| 1626 | + | provided by this subsection shall not apply to substance abuse |
---|
| 1627 | + | treatment programs or services. |
---|
| 1628 | + | SECTION 13. This act shall become effective Novemb er 1, 2021. |
---|